Home > Insider Trading > Filing (0001209191-20-049778)

Filing Details

Accession Number:: 0001209191-20-049778
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-09-08 18:14:10
Reporting Period:: 2020-09-03

Accepted Time:: 2020-09-08 18:14:10
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1304492	Anterix Inc.	ATEX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
937846	E Morgan Obrien	3 Garret Mountain Plaza Suite 401 Woodland Park NJ 07424	Executive Chairman	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-09-03	26,009	$0.00	108,600	No	4	A	Direct
Common Stock	Disposition	2020-09-04	9,715	$42.30	98,885	No	4	S	Direct
Common Stock	Disposition	2020-09-08	4,635	$40.18	94,250	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Acquisiton	2020-09-03	26,464	$0.00	26,464	$46.85

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
26,464	2020-09-03	2025-08-29	No	4	A	Direct

Footnotes

On February 28, 2020, the Reporting Person was granted a performance-based restricted stock unit award (the "RSU"), which vests in two tranches upon the Issuer achieving certain performance milestones prior to December 30, 2020. The Compensation Committee determined that the performance milestone for the first tranche was satisfied, resulting in the vesting of the reported shares of common stock under the RSU.
Represents shares sold to satisfy tax withholding obligations in connection with the partial vesting and settlement of restricted stock units granted August 2018 and February 2020.
This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $42.00 to $42.63. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $39.92 to $40.85. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
On February 28, 2020, the Reporting Person was granted a performance-based stock option, which vests in two tranches upon the Issuer achieving certain performance milestones prior to December 30, 2020. The Compensation Committee determined that the performance milestone for the first tranche was satisfied, resulting in the vesting of the reported shares of common stock under the stock option.